INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 433m ago
HOUSE PTR33m ago
SEC 13F33m ago
ROBINHOOD CHAIN33m ago
Corporate insider
SK

Stueland Katherine

Director, CHIEF EXECUTIVE OFFICERCIK 0001689575

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 7
Max Insider Score40
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
18.8K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    GeneDx Holdings Corp.Director, CHIEF EXECUTIVE OFFICER · Dec 11, 2025
28
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL
$301K
3,039 sh
Sep 16, 2026
Sep 18, 2026
traded Sep 16, 2026
+2d
SEC FORM 4

Evidence

25
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$148K
1,525 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

28
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$407K
4,141 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

17
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
18.8K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

25
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$155K
1,648 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

22
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$14K
148 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

5
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
6,547 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC FORM 4

Evidence

28
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$311K
3,692 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC FORM 4

Evidence

9
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
6,547 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC FORM 4

Evidence

21
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
6,547 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence

40
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$580K
3,639 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence

17
SK
Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
6,547 sh
Dec 9, 2025Dec 11, 2025
traded Dec 9, 2025
+2dSEC FORM 4

Evidence